Clinical Trial Update: Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating induction chemotherapy followed by concurrent chemoradiotherapy for stage III non-small cell lung cancer, stratified by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Lung Cancer, NSCLC | Phase 2 | Status: UNKNOWN